Hills Bank & Trust’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $261K | Buy |
1,334
+40
| +3% | +$7.77K | 0.01% | 269 |
|
|
2025
Q4 | $225K | Sell |
1,294
-5
| -0.4% | -$910 | 0.01% | 265 |
|
|
2025
Q3 | $248K | Sell |
1,299
-32
| -2% | -$5.68K | 0.01% | 250 |
|
|
2025
Q2 | $239K | Hold |
1,331
| – | – | 0.02% | 245 |
|
|
2025
Q1 | $225K | Sell |
1,331
-96
| -7% | -$15.8K | 0.02% | 242 |
|
|
2024
Q4 | $215K | Sell |
1,427
-300
| -17% | -$46.7K | 0.02% | 239 |
|
|
2024
Q3 | $268K | Hold |
1,727
| – | – | 0.02% | 229 |
|
|
2024
Q2 | $236K | Sell |
1,727
-1
| -0.1% | -$137 | 0.02% | 229 |
|
|
2024
Q1 | $230K | Sell |
1,728
-62
| -3% | -$8.04K | 0.02% | 228 |
|
|
2023
Q4 | $247K | Hold |
1,790
| – | – | 0.02% | 208 |
|
|
2023
Q3 | $218K | Sell |
1,790
-4
| -0.2% | -$533 | 0.03% | 203 |
|
|
2023
Q2 | $252K | Hold |
1,794
| – | – | 0.03% | 185 |
|
|
2023
Q1 | $254K | Hold |
1,794
| – | – | 0.04% | 183 |
|
|
2022
Q4 | $281K | Hold |
1,794
| – | – | 0.04% | 174 |
|
|
2022
Q3 | $220K | Sell |
1,794
-130
| -7% | -$17.1K | 0.03% | 185 |
|
|
2022
Q2 | $256K | Sell |
1,924
-115
| -6% | -$15.7K | 0.04% | 179 |
|
|
2022
Q1 | $279K | Sell |
2,039
-2
| -0.1% | -$279 | 0.04% | 178 |
|
|
2021
Q4 | $353K | Hold |
2,041
| – | – | 0.05% | 166 |
|
|
2021
Q3 | $297K | Hold |
2,041
| – | – | 0.04% | 171 |
|
|
2021
Q2 | $269K | Hold |
2,041
| – | – | 0.04% | 176 |
|
|
2021
Q1 | $262K | Sell |
2,041
-150
| -7% | -$18.5K | 0.04% | 174 |
|
|
2020
Q4 | $261K | Hold |
2,191
| – | – | 0.05% | 170 |
|
|
2020
Q3 | $251K | Sell |
2,191
-100
| -4% | -$11.8K | 0.05% | 160 |
|
|
2020
Q2 | $261K | Buy |
+2,291
| New | +$243K | 0.06% | 158 |
|
|
2020
Q1 | – | Sell |
-2,301
| Closed | -$246K | – | 154 |
|
|
2019
Q4 | $246K | Hold |
2,301
| – | – | 0.06% | 145 |
|
|
2019
Q3 | $246K | Hold |
2,301
| – | – | 0.06% | 138 |
|
|
2019
Q2 | $234K | Hold |
2,301
| – | – | 0.06% | 145 |
|
|
2019
Q1 | $207K | Sell |
2,301
-130
| -5% | -$11.3K | 0.06% | 152 |
|
|
2018
Q4 | $203K | Sell |
2,431
-44
| -2% | -$4.13K | 0.06% | 136 |
|
|
2018
Q3 | $268K | Hold |
2,475
| – | – | 0.07% | 125 |
|
|
2018
Q2 | $272K | Hold |
2,475
| – | – | 0.08% | 120 |
|
|
2018
Q1 | $248K | Sell |
2,475
-35
| -1% | -$3.58K | 0.07% | 119 |
|
|
2017
Q4 | $247K | Hold |
2,510
| – | – | 0.07% | 121 |
|
|
2017
Q3 | $235K | Sell |
2,510
-50
| -2% | -$5.31K | 0.07% | 122 |
|
|
2017
Q2 | $285K | Buy |
2,560
+35
| +1% | +$3.7K | 0.09% | 113 |
|
|
2017
Q1 | $248K | Hold |
2,525
| – | – | 0.08% | 118 |
|
|
2016
Q4 | $232K | Hold |
2,525
| – | – | 0.08% | 121 |
|
|
2016
Q3 | $213K | Hold |
2,525
| – | – | 0.08% | 124 |
|
|
2016
Q2 | $206K | Buy |
+2,525
| New | +$192K | 0.08% | 122 |
|
|
2015
Q2 | – | Sell |
-2,750
| Closed | -$211K | – | 85 |
|
|
2015
Q1 | $211K | Buy |
+2,750
| New | +$197K | 0.08% | 83 |
|
Other funds holding DGX
VCM
VPM
EIG
Hills Bank & Trust's DGX Position: Q1 2026 in Review
Hills Bank & Trust increased its Quest Diagnostics (DGX) stake by 3.1% in Q1 2026, buying an estimated $7.77K and bringing the position to 1,334 shares worth $261K. The position accounts for 0.01% of the portfolio, ranked #269.
Hills Bank & Trust first reported a position in DGX in Q1 2015 and has held it in 40 quarters since. The position peaked at $353K in Q4 2021. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Hills Bank & Trust held 1,334 shares of Quest Diagnostics worth $261K as of Q1 2026.
- Hills Bank & Trust bought 40 Quest Diagnostics shares in Q1 2026, an estimated $7.77K.
- Quest Diagnostics made up 0.01% of Hills Bank & Trust's portfolio in Q1 2026, its #269 holding.
- Hills Bank & Trust first reported a position in Quest Diagnostics in Q1 2015 and has held it in 40 quarters since.
- Hills Bank & Trust's Quest Diagnostics position peaked at $353K in Q4 2021.
- 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Hills Bank & Trust's 13F filing for Q1 2026, filed 1 May 2026.